JPRN-UMIN000009298
Recruiting
Phase 2
Phase II study of elental for chemotherapy induced mucositis oral and nutritional disturbance - Phase II study of elental for chemotherapy induced mucositis oral and nutritional disturbance
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Aizawa Hospital
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)severe symptom with cancer 2\)difficult to take elental due to other gastro intestinal symptoms 3\)recieve other treatment for oral mucositis 4\)physician judged inadequate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
The phase II study of induction chemotherapy with cetuximab/S-1/low dose cisplatin for oral squamous cell carcinoma patientsoral squamous cell carcinomaJPRN-UMIN000014632The workshop of chemotherapy for oral cancer55
Active, not recruiting
Not Applicable
Phase II study to evaluate the efficacy of a chemotherapy combination with Imatinib (Glivec®) and 5-FU/leucovorin in patients with advanced carcinoma of the gallbladder and bile duct - TUD-Glivec-012advanced carcinoma of the gallbladder and bile ductEUCTR2006-003451-20-DETechnical University Dresden44
Recruiting
Phase 2
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancerpancreatic cancerC535836JPRN-jRCT1041230068Ebata Tomoki50
Completed
Phase 2
Phase II study of Chemotherapy for Advanced or Recurrent ThymomaThymoma (excluding thymic carcinoma)JPRN-C000000350Japanese Association for Research on the Thymus50
Completed
Phase 2
A phase II study of first line chemotherapy by eribulin mesilate for HER2 negative recurrent breast cancerBreast cancerJPRN-UMIN000007990Kobe Breast Cancer Oncology Group35